Ergoteles LLC Heron Therapeutics, Inc. Transaction History

Ergoteles LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$2.25 - $4.67 $31,466 - $65,309	-13,985 Reduced 10.44%	119,967 $299,000
Q3 2022 Nov 14, 2022	BUY	$2.66 - $5.37 $356,312 - $719,322	133,952 New	133,952 $565,000
Q1 2022 May 13, 2022	SELL	$4.63 - $9.94 $464,060 - $996,276	-100,229 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.35 - $12.6 $587,372 - $886,334	70,344 Added 235.38%	100,229 $915,000
Q3 2021 Nov 15, 2021	BUY	$10.13 - $15.0 $302,735 - $448,275	29,885 New	29,885 $319,000

179

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.